Atrás
Rango del Día
$67.00
$71.57
Rango de 52 Semanas
$66.50
$112.30
Volumen
200
Promedio 50D / 200D
$82.13
/
$89.63
Cierre Anterior
$70.76
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 19.2 | 0.4 |
| P/B | 2.0 | 2.9 |
| ROE % | 11.3 | 3.7 |
| Net Margin % | 15.9 | 3.8 |
| Rev Growth 5Y % | 7.7 | 10.0 |
| D/E | 0.6 | 0.2 |
Puntos Clave
Revenue grew 7.69% annually over 5 years — modest growth
Earnings grew 17.68% over the past year
ROE of 11.27% — decent returns on equity
Net margin of 15.87% shows strong profitability
Generating 239.07M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.45%
Crecimiento
Revenue Growth (5Y)
7.69%
Revenue (1Y)3.24%
Earnings (1Y)17.68%
FCF Growth (3Y)-6.87%
Calidad
Return on Equity
11.27%
ROIC6.88%
Net Margin15.87%
Op. Margin21.79%
Seguridad
Debt / Equity
0.56
Current Ratio3.39
Interest Coverage9.03
Valoración
P/E Ratio
19.21
P/B Ratio2.01
EV/EBITDA16.58
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.24% | Revenue Growth (3Y) | -6.68% |
| Earnings Growth (1Y) | 17.68% | Earnings Growth (3Y) | -11.64% |
| Revenue Growth (5Y) | 7.69% | Earnings Growth (5Y) | -6.67% |
| Profitability | |||
| Revenue (TTM) | 1.19B | Net Income (TTM) | 188.11M |
| ROE | 11.27% | ROA | 5.69% |
| Gross Margin | 65.94% | Operating Margin | 21.79% |
| Net Margin | 15.87% | Free Cash Flow (TTM) | 239.07M |
| ROIC | 6.88% | FCF Growth (3Y) | -6.87% |
| Safety | |||
| Debt / Equity | 0.56 | Current Ratio | 3.39 |
| Interest Coverage | 9.03 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 19.21 | P/B Ratio | 2.01 |
| P/S Ratio | 3.05 | PEG Ratio | 1.76 |
| EV/EBITDA | 16.58 | Dividend Yield | 0.01% |
| Market Cap | 3.61B | Enterprise Value | 4.28B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 1.15B | 1.36B | 1.24B | 881.31M |
| Net Income | 188.11M | 159.85M | 240.91M | 310.97M | 247.87M |
| EPS (Diluted) | 3.37 | 2.87 | 4.15 | 5.40 | 4.50 |
| Gross Profit | 781.70M | 741.19M | 900.61M | 824.77M | 602.91M |
| Operating Income | 258.33M | 216.26M | 351.26M | 419.50M | 324.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3.30B | 3.21B | 3.41B | 3.23B | 1.25B |
| Total Liabilities | 1.51B | 1.67B | 1.89B | 1.86B | 290.13M |
| Shareholders' Equity | 1.80B | 1.54B | 1.52B | 1.37B | 954.68M |
| Total Debt | 1.01B | 1.19B | 1.35B | 1.40B | 34.66M |
| Cash & Equivalents | 344.27M | 280.31M | 241.78M | 403.02M | 339.88M |
| Current Assets | 932.53M | 982.69M | 1.07B | 958.29M | 713.92M |
| Current Liabilities | 275.30M | 320.12M | 347.02M | 298.23M | 160.21M |